Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine

Epidemiology of Japanese Encephalitis in India: Analysis of laboratory surveillance data, 2014–2017

(2018) Kaliaperumal Kanagasabai et al.   JOURNAL OF INFECTION

Acute Encephalitis Syndrome in Gorakhpur, Uttar Pradesh, 2016

(2018) Mahima Mittal et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Antibody Persistence up to 3 Years after Primary Immunization with Inactivated Japanese Encephalitis Vaccine IXIARO® in Philippine Children and Effect of a Booster Dose

(2018) Vera Kadlecek et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1:4 matched case-control study

(2018) Babasaheb V. Tandale et al.   Journal of Infection and Public Health

Incidence of Japanese Encephalitis amongst acute encephalitis syndrome cases in upper Assam districts from 2012 to 2014: A report from a tertiary care hospital

(2017) Mithu Medhi et al.   INDIAN JOURNAL OF MEDICAL RESEARCH

Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015: Implications for Japanese encephalitis control

(2017) ManojV Murhekar et al.   INDIAN JOURNAL OF MEDICAL RESEARCH

Aetiology of acute encephalitis syndrome in Uttar Pradesh, India from 2014 to 2016

(2017) Amita Jain et al.   JOURNAL OF VECTOR BORNE DISEASES

Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region

(2017) Katrin L. Dubischar et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease

(2017) Nagendra R. Hegde et al.   Human Vaccines & Immunotherapeutics

Cellular Immune Responses to Live Attenuated Japanese Encephalitis (JE) Vaccine SA14-14-2 in Adults in a JE/Dengue Co-Endemic Area

(2017) Lance Turtle et al.   PLoS Neglected Tropical Diseases

Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults

(2016) Yuka Saito et al.   BMC INFECTIOUS DISEASES

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

(2016) Lalita Priyamvada et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

An appraisal of clinicopathological parameters in Japanese encephalitis and changing epidemiological trends in upper Assam, India

(2016) SauravJyoti Patgiri et al.   Indian Journal of Pathology and Microbiology

A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains

(2015) Anit Singh et al.   JOURNAL OF INFECTIOUS DISEASES

The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children

(2015) Hyo Jin Kwon et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis

(2015) Maria Paulke-Korinek et al.   VACCINE

Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2013 and updates on immunization

(2013) Vipin M. Vashishtha et al.   INDIAN PEDIATRICS

Incidence of Japanese Encephalitis among Acute Encephalitis Syndrome Cases in West Bengal, India

(2013) Bhaswati Bandyopadhyay et al.   Biomed Research International

Estimated global incidence of Japanese encephalitis:

(2011) Grant Campbell et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51

(2011) Susanne Eder et al.   VACCINE

Japanese Encephalitis in Travelers from Non-Endemic Countries, 1973–2008

(2010) Susan L. Hills et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities

(2010) Yongxin Yu   VACCINE

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study

(2009) Elisabeth Schuller et al.   VACCINE

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51

(2008) E. Schuller et al.   VACCINE